Fig. 7From: Recombinant PAL/PilE/FlaA DNA vaccine provides protective immunity against Legionella pneumophila in BALB/c miceProtective immunity in mice after a lethal dose challenge with Legionella pneumophila. The survival rate of mice for 10 days after a lethal dose challenge with Legionella pneumophila was shown (n = 10)Back to article page